Ancient Wheats and Gluten Sensitivity: The Diploid Hypothesis

A pattern keeps showing up in my inbox. Someone reacts badly to a slice of supermarket sourdough, switches to an einkorn loaf from a heritage baker, and reports the symptoms vanish. They want to know whether the difference is real, or whether they’ve talked themselves into feeling better. The honest answer is: probably some of both, and the genetics gives us a reasonable mechanism to explain the part that is real.

This post is about what changes when a wheat species carries fewer chromosomes, why those changes matter for the immune response to gluten, and where the clinical evidence is genuinely strong, weakly suggestive, or simply absent. One thing it is not about: celiac disease. If you have celiac, einkorn is not a workaround. We will come back to that.

What changes when wheat gains chromosomes?

Wheat is a polyploid mess. Going up the family tree:

Wheat	Chromosomes	Genome	When it appeared
Einkorn (Triticum monococcum)	2n=14	AmAm	~10,000 BCE
Emmer / durum / khorasan (T. turgidum)	2n=28	AABB	~10,000 BCE
Modern bread wheat / spelt (T. aestivum)	2n=42	AABBDD	~6,000–8,000 BCE

Einkorn is diploid: two sets of one genome (A). Emmer is tetraploid (A and B genomes). Bread wheat is hexaploid, having added a third genome (D) by hybridising with a goat-grass called Aegilops tauschii about 8,000 years ago. The 2023 Nature paper from Wang and colleagues sequenced einkorn and traced exactly this lineage in unprecedented detail (Wang et al. 2023, Nature). Each genome carries its own copies of the gluten protein genes (gliadins and glutenins), and they are not equally well-behaved.

The most reactive gluten epitopes live on the D genome

If you are going to map where the immune system gets angry, the place to look is the alpha-gliadin family. The foundational paper here is van Herpen and colleagues (van Herpen et al. 2006, BMC Genomics), who showed that alpha-gliadin genes from the D genome contain the highest density of celiac-disease epitopes, while the B genome contains the fewest.

A single peptide does most of the heavy lifting: a 33-amino-acid fragment of alpha-gliadin known as the 33-mer, which carries six overlapping epitopes recognised by celiac T-cells. Ozuna and colleagues compared the 33-mer across wheat species and found it present in hexaploid bread wheat but absent in diploid einkorn and tetraploid emmer/durum (Ozuna et al. 2015, Plant Journal). A follow-up paper traced the 33-mer specifically to the D-genome donor, confirming it entered the human food supply only when wheat became hexaploid (Schaart et al. 2021, Plant Journal).

In other words: einkorn lacks the worst single peptide. It still carries other immunogenic alpha-gliadin epitopes from its A genome, so “lacks the 33-mer” is not the same as “lacks gluten.” It is gluten with a less aggressive set of red flags.

What the celiac evidence actually shows

The mechanistic story has tempted researchers to test einkorn directly in celiac patients. The results are interesting and a useful object lesson in why mechanism is not destiny.

In an in vitro organ-culture study, einkorn gliadin failed to produce the morphological and immune changes in celiac duodenal biopsies that bread-wheat gliadin reliably triggers (Pizzuti et al. 2006, Scand J Gastroenterol). A single-blind acute challenge in celiac patients showed no immediate change in intestinal permeability (Zanini et al. 2013, BMC Gastroenterology).

So far so encouraging. And yet, when the same group ran a 60-day daily-exposure phase II study, 60% of celiac patients seroconverted, meaning their celiac antibodies rose into positive territory (Zanini et al. 2015, Eur J Nutr). The acute studies missed the chronic effect entirely. This is the citation any honest writer should put at the top of their einkorn page. Einkorn is not a celiac food.

What about non-celiac wheat sensitivity?

Outside of celiac is where the diploid hypothesis has its most plausible footing, but the trial data is thinner than the popular narrative suggests.

A small observational evaluation of NCWS patients voluntarily switching to ancient grains reported variable but generally improved symptoms (Seidita et al. 2022, Front Med). The authors flag this as preliminary and hypothesis-generating, not a controlled trial.

The cleanest randomized data we have works against the popular framing. In two recent crossover RCTs, NCWS patients showed no significant group-level difference between bread wheat, spelt, and emmer breads (de Graaf et al. 2024, AJCN). Notably, this trial did not include einkorn, and individual responses still varied. So the strongest randomized evidence neither confirms nor refutes that diploid einkorn specifically is better tolerated.

The honest summary: if you have non-celiac wheat sensitivity, einkorn might help you, and there is a plausible mechanism, but the proof is not there yet at the level of a clinical recommendation.

Modern wheat does not actually have “more gluten”

This part of the story has been overstated for years. A careful 2022 review concluded that ancient wheats often have equal or higher total gluten and protein than modern bread wheat, with protein declining slightly in modern varieties as starch content has gone up under yield-driven breeding (Brouns, Geisslitz, Shewry 2022, Nutrition Bulletin). What has changed is the composition of gluten: the ratios of high-molecular-weight glutenin, low-molecular-weight glutenin, and omega-gliadin subunits, not the total amount (De Santis et al. 2017, J Cereal Sci).

So if you are arguing that einkorn might suit you better, do not lean on the “modern wheat has more gluten” claim. Lean on the “different and arguably less reactive proteins” claim. That one survives scrutiny.

Maybe it isn’t gluten at all

For people who react to bread but who do not have celiac, two non-gluten suspects deserve airtime.

Fructans, a class of FODMAP carbohydrates, are concentrated in wheat. In a placebo-controlled rechallenge, gluten produced symptoms in only 8% of self-reported NCGS subjects when FODMAPs were controlled (Biesiekierski et al. 2013, Gastroenterology). A follow-up trial showed fructan challenge induced more symptoms than gluten challenge (Skodje et al. 2018, Gastroenterology).

Amylase trypsin inhibitors (ATIs), a separate class of wheat proteins, activate Toll-like receptor 4 and drive intestinal inflammation in mouse and cell-culture work (Junker et al. 2012, J Exp Med). ATI levels vary by cultivar more than by ploidy, so do not assume einkorn is automatically low-ATI.

The point: if your symptoms are FODMAP-mediated, an einkorn loaf will not necessarily save you, and a long sourdough fermentation of any wheat probably will. If they are ATI-mediated, you need to look at cultivar, not ploidy.

What this means in your kitchen

Treat this as a falsifiable experiment, not a doctrine.

1. If you have celiac disease: einkorn is not safe. Stick to certified gluten-free grains. Our buckwheat and teff pages are a good starting point.
2. If you have non-celiac wheat sensitivity and want to try diploid wheat: cook with einkorn for two weeks, then reintroduce a comparable modern-wheat loaf and notice the difference (or its absence). One test, well controlled, beats a year of internet reading.
3. If you suspect FODMAPs: a long-fermented sourdough of any wheat reduces fructan content substantially. The ancient grain bread guide covers the technique.

The diploid hypothesis is not a cure. It is a plausible mechanism with patchy clinical support, sitting inside a much messier conversation about what people actually react to. But on the bright side, you do not need a randomized controlled trial to know what your own gut tells you. Pick a heritage variety, run the experiment honestly, and trust the result you get.